Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 162
NON-VALVULAR ATRIAL FIBRILLATION (AFIB)/A-FLUTTER
STATUS SUMMARY
(Updated 03/27/2024)
Name ______________________________ Birthdate _______________________________
Applicant ID# ___________________________ PI# ____________________________________
Instructions:
• Please have the cardiologist who treats your AFib or A-Flutter complete, sign, and date this sheet or
submit a current, detailed Clinical Progress Note that addresses ALL items below.
• Return this sheet (or a current, Detailed Clinical Progress note from the cardiologist) AND a current
cardiac monitor report to your AME for electronic upload to the FAA:
NO YES*
1. Has the patient’s condition worsened within the past year? (Check YES* if there are any
required or recommended treatment changes, procedures, if stroke risk factors [e.g.,
hypertension, hyperlipidemia] have not been well controlled, any bleeding episodes requiring
medical attention, or other concerns.)..........................................................................................
NO YES*
2. Is there a definitive or suspicious history for stroke, TIA, or any other thromboembolic event?
3. Is treatment for AFib/A-Flutter currently indicated? If YES*, identify reason(s) AND
NOT indicated YES*
treatment* (circle): Symptoms Rate control Rhythm control Other_____________
OR Indicated
Treatment _______________________________________________________________
NO problems but NOT
With being
4. What is your patient’s current CHA2DS2-VASc score? (Circle components for score.)
treatment treated*
CHA2DS2-
Congestive heart failure 1 Vascular disease (prior MI, PAD, or 1
VASc score
Hypertension 1 aortic plaque/atheroma)
Age > = 75 2
Age 65-74 1
Diabetes mellitus 1
Female (Male = 0) 1
Previous stroke/TIA/TE 2
5. If CHA2DS2-VASc is 2 or more, is the patient treated with NOAC/DOAC, LAA closure, or
Treatment *Indicated
warfarin (Jantoven)? Warfarin (Jantoven) requires 6 weeks of stabilization with 80% of INRs
NOT but NOT
between 2.0 and 3.0. Submit a copy of the last 6 monthly INR values.
indicated treated
OR OR
If other emboli mitigation strategy utilized, describe: ________________________________
treatment goals
goals met NOT met
6. Does a current ≥ 24hr cardiac monitor show poor rate control or is the patient functionally
symptomatic? (Address any concerns if average heart rate is > 100, maximum [non-
NO YES*
exertional] is > 120, or a single pause is > 3 seconds. You must submit the 1-page
computerized summary and the representative full-scale multi-lead ECG tracings, EVEN IF
FINDINGS ARE NORMAL.)
7. Is the patient non-compliant or not tolerating AFib/A-Flutter treatment and/or emboli mitigation
NO YES*
medication? (Also check YES* if significant side effects.) ........................................
8. Describe any significant clinical history changes since last evaluation, any YES* items, or
other concerns:
__________________________________________________________________________
___________________________________________________________________________________________________________________________
_____________________________ _____________________
Cardiologist Signature Date of evaluation
AME instructions:
INITIAL A-Fib consideration. AME must defer.
Recertification. If the pilot has a valid AASI for Atrial Fibrillation and each item on the AFib/A-Flutter Status Summary is in the left-hand column
(NO “yes” answers) follow AASI instructions.
IF ANY ANSWER FALLS IN YES* COLUMN ABOVE, THE AME MUST DEFER.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026, page 162. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source.